Yijian Zhu

Yijian Zhu

Auto-generated profile, based on publicly available information

Yijian Zhu

Department of Dermatology, Huashan Hospital, Fudan University , Shanghai

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2024 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
YZYijian Zhu
Yijian Zhu
ZSZhengzhou Shi
Zhengzhou Shi
ZXZhongyi Xu
Zhongyi Xu
SLSuqing Liu
Suqing Liu
JZJian Zhang
Jian Zhang
LXLeihong Xiang
Leihong Xiang

12 June 2012 in Epidemiology and Infection
Verified
Journal Article
Open access
PDF file
YZY. Zhu
Y. Zhu
ZYZ. Yuan
Z. Yuan
QZQ. Zhao
Q. Zhao
GCG. Chen
G. Chen
BXB. Xu
B. Xu
SUMMARY: This study aimed to determine current seroprevalence of hepatitis A virus (HAV) antibody in subjects aged 0–30 years in Shanghai. A total of 5515 subjects were recruited through random clustering sampling in 2009. Basic clinical and demographic information and records of HAV vaccination were acquired by questionnaire interviews and review of immunization records. Serum samples were collected and tested for anti-HAV IgM and total anti-HAV. The overall seroprevalence of total anti-HAV was 52·9%. Subjects aged 20–24 years had the lowest (34·4%) anti-HAV seropositivity and subjects aged 5–9 years had the highest (74·6%) positivity. Seroprevalence was significantly greater in subjects from suburban areas than in subjects from urban areas. Subjects who had HAV immunizations had significantly greater seropositivity for total anti-HAV. Previous hepatitis A immunization policies had a significant impact on the presence of anti-HAV seroprevalence in a population aged 0–30 years from Shanghai.

21 August 2024 in Pigment Cell & Melanoma Research
Verified
Journal Article
Closed access
YDYanjun Dan
Yanjun Dan
LCLi Chen
Li Chen
SJShanglin Jin
Shanglin Jin
XXXiaoxue Xing
Xiaoxue Xing
YZYijian Zhu
Yijian Zhu
LXLeihong Xiang
Leihong Xiang

17 February 2025 in Pigment Cell & Melanoma Research
Verified
Journal Article
Closed access
LZLi Zhang
Li Zhang
JZJian Zhang
Jian Zhang
SLSuqing Liu
Suqing Liu
ZSZhengzhou Shi
Zhengzhou Shi
YZYijian Zhu
Yijian Zhu
LXLeihong Xiang
Leihong Xiang

1 March 2026 in Journal of Advanced Research
Verified
Journal Article
Open access
YZYijian Zhu
Yijian Zhu
SLSuqing Liu
Suqing Liu
CWChen Wang
Chen Wang
ZXZhongyi Xu
Zhongyi Xu
ZSZhengzhou Shi
Zhengzhou Shi
MJMin Jiang
Min Jiang
Vitiligo is an acquired depigmenting disorder. Current repigmentation strategies aim to prevent melanocyte loss and promote regeneration, often by enhancing the differentiation of melanocyte progenitors. However, acral vitiligo, lacking hair follicles, exhibits poor therapeutic response. Platelet-rich plasma (PRP) may offer an alternative approach, but its effects on dermal melanocyte progenitors (DMPs) remain unclear. To evaluate the therapeutic effect and mechanisms of PRP and 308-nm excimer phototherapy in refractory vitiligo. We conducted a single-center, prospective, randomized split-body clinical observation (n = 30, with 20 split-body and 10 PRP-only) to assess the effectiveness of PRP combined with 308-nm excimer phototherapy in patients with stable acral vitiligo over a 5-month treatment duration. A defined induction system was established to generate functional melanocytes. Bulk and single-cell RNA sequencing analyzed phenotypic changes. A glabrous skin organoid model was established to study acral melanocyte regeneration and assess PRP's effects. Protein microarray was used to identify key effectors in PRP. Clinically, PRP combined with phototherapy significantly improved repigmentation in acral vitiligo, presenting a diffuse pattern on the palms and distal fingers. Pigment index improvements in the PRP + 308 vs. NS + 308 groups were observed on the dorsum (44.30 ± 6.17 vs 36.40 ± 4.94), palms (20.15 ± 3.10 vs 16.45 ± 4.73), proximal fingers (31.75 ± 3.73 vs 29.00 ± 3.52), and distal fingers (19.90 ± 3.88 vs 19.45 ± 3.80). Palm repigmentation correlated with the activation of DMPs. In vitro and in vivo transcriptomic analyses demonstrated a defined differentiation trajectory from DMPs to melanocytes. In both cell-based and glabrous skin organoid models, PRP promotes melanocyte differentiation. IGFBP-2 was identified as a key effector in PRP through the IGFBP-2/RhoA/YAP signaling axis. PRP renders additional clinical benefits in the treatment of acral vitiligo through activation of the IGFBP-2/RhoA/YAP signaling to drive DMP-to-melanocyte differentiation. This establishes DMPs as a novel, follicle-independent melanocyte source and supports a promising therapeutic strategy for treatment-resistant vitiligo.

15 January 2026 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
XXXiaoxue Xing
Xiaoxue Xing
JRJie Ren
Jie Ren
YZYijian Zhu
Yijian Zhu
YLYi Lin
Yi Lin
ZXZhongyi Xu
Zhongyi Xu
LXLeihong Xiang
Leihong Xiang